Zincshot Injection contains Zinc Chloride at a concentration of 1 mg/ml and is indicated for the treatment and prevention of zinc deficiency in patients where oral supplementation is not feasible or effective. Zinc is an essential trace element involved in numerous enzymatic reactions critical for cellular metabolism, immune function, wound healing, and DNA synthesis. Zincshot Injection provides a reliable parenteral source of zinc, ensuring rapid correction of deficiency states. It is particularly useful in cases of malabsorption syndromes, chronic diarrhea, burns, chronic liver disease, or in patients receiving total parenteral nutrition. Administration should be performed by healthcare professionals, with dosage tailored according to the patient’s clinical condition and serum zinc levels. Caution is advised in patients with renal impairment or those receiving concurrent chelating agents, as altered zinc metabolism may occur. Adverse reactions are uncommon but may include local irritation at the injection site, hypersensitivity reactions, or gastrointestinal disturbances if inadvertently administered intravenously. Regular monitoring of zinc levels and clinical response is recommended during therapy. Zincshot Injection should be stored at controlled room temperature, protected from light and moisture. This formulation offers an effective alternative for zinc supplementation when oral administration is contraindicated or insufficient.